ciprofloxacin has been researched along with Bacterial Infections, Gram-Positive in 111 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the study was to describe the incidence and type of bacterial infections associated with the use of ciprofloxacin prophylaxis as single agent in pediatric patients with acute myeloid leukemia (AML)." | 7.85 | Bacterial Infections in Children With Acute Myeloid Leukemia Receiving Ciprofloxacin Prophylaxis. ( Al Omar, S; Al Qasem, W; Anabtawi, N; Rihani, R, 2017) |
| "We present the results of a protocol of empiric monotherapy of continuous ambulatory peritoneal dialysis (CAPD)-related peritonitis with ciprofloxacin (CPX), with a special emphasis on the evolution of our results after seven years of continued use of this drug." | 7.69 | Treatment of CAPD-related peritonitis with ciprofloxacin: results after seven years. ( Bouza, P; García Falcón, T; López Vázquez, M; Pérez Fontán, M; Rodríguez-Carmona, A; Tresancos, C; Valdés, F, 1996) |
| " Ten adverse events were observed in seven patients and in four (7%) of these treatment had to be withdrawn." | 6.67 | Study of the efficacy and safety of ciprofloxacin in the treatment of chronic sinusitis. ( Barrault, S; Dobler, S; Ebbo, D; Fombeur, JP; Koubbi, G; Laurier, JN; Lecomte, F; Sorrel, N, 1994) |
| "The objective of this multicenter, randomized, controlled, parallel group trial was to evaluate the efficacy of levofloxacin 250 mg oral, once daily (LVFX), placebo one tablet oral once daily (Placebo [P] group) and ciprofloxacin (CPFX) 500 mg oral, twice daily (single blind), prophylaxis in preventing bacteriuria (> or = 10(3) CFU/ml) in post-surgical catheterized patients." | 5.12 | A pilot study on prevention of catheter-related urinary tract infections with fluoroquinolones. ( Drago, L; Esposito, S; Leone, S; Marchetti, F; Marvaso, A; Noviello, S, 2006) |
| "To determine whether the addition of rifampin to a quinolone-based antibacterial prophylactic regimen in patients undergoing high-dose chemotherapy (HDC) with peripheral-blood stem-cell transplantation (PBSCT) decreases the incidence of neutropenia and fever, Gram-positive bacteremia, and infection-related morbidity." | 5.09 | Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial. ( Arcediano, A; Cortés-Funes, H; Gomez-Martin, C; Hidalgo, M; Hornedo, J; Lumbreras, C; Perea, S; Rodriguez, M; Salazar, R; Solá, C; Valentí, V, 2000) |
| " For treatment of uncomplicated VRE urinary tract infections, ciprofloxacin or nitrofurantoin can be used." | 4.98 | [Treatment of vancomycin-resistant enterococcal infections]. ( Holzknecht, BJ; Justesen, US; Lund, LC, 2018) |
| "The aim of the study was to describe the incidence and type of bacterial infections associated with the use of ciprofloxacin prophylaxis as single agent in pediatric patients with acute myeloid leukemia (AML)." | 3.85 | Bacterial Infections in Children With Acute Myeloid Leukemia Receiving Ciprofloxacin Prophylaxis. ( Al Omar, S; Al Qasem, W; Anabtawi, N; Rihani, R, 2017) |
| "We present the results of a protocol of empiric monotherapy of continuous ambulatory peritoneal dialysis (CAPD)-related peritonitis with ciprofloxacin (CPX), with a special emphasis on the evolution of our results after seven years of continued use of this drug." | 3.69 | Treatment of CAPD-related peritonitis with ciprofloxacin: results after seven years. ( Bouza, P; García Falcón, T; López Vázquez, M; Pérez Fontán, M; Rodríguez-Carmona, A; Tresancos, C; Valdés, F, 1996) |
| "Intravenous ciprofloxacin is approved for the treatment of urinary tract, bone and joint, skin and soft tissue, and lower respiratory tract infections." | 3.68 | Intravenous ciprofloxacin: a position statement by the Society of Infectious Diseases Pharmacists. ( , 1993) |
| "ciprofloxacin was at least equivalent to imipenem in terms of bacteriological eradication and clinical response." | 2.69 | Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia. ( Caldwell, JW; Johnson, RH; Singh, S, 1999) |
| " Ten adverse events were observed in seven patients and in four (7%) of these treatment had to be withdrawn." | 2.67 | Study of the efficacy and safety of ciprofloxacin in the treatment of chronic sinusitis. ( Barrault, S; Dobler, S; Ebbo, D; Fombeur, JP; Koubbi, G; Laurier, JN; Lecomte, F; Sorrel, N, 1994) |
| "Cutaneous diphtheria is a rare infection in the United States." | 2.44 | Cutaneous diphtheroid infection and review of other cutaneous Gram-positive Bacillus infections. ( English, JC; Lee, PL; Lemos, B; O'Brien, SH; Zirwas, MJ, 2007) |
| "Patients who are treated for acute leukemia should be offered prophylaxis with ciprofloxacin or levofloxacin." | 2.43 | Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions. ( Bucaneve, G; Cullen, M; Fraser, A; Gafter-Gvili, A; Kern, WV; Leibovici, L; Paul, M, 2006) |
| "In a mouse skin wound infection model, F6 was equipotent to the antibiotic fusidic acid in reducing MRSA burden." | 1.48 | N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria. ( Abutaleb, NS; Dayal, N; Mohammad, H; Naclerio, GA; Opoku-Temeng, C; Seleem, MN; Sintim, HO, 2018) |
| "Gatifloxacin showed lower resistance levels than moxifloxacin." | 1.38 | [In vitro antibiotic susceptibility to fluoroquinolones]. ( Galvis, V; Rey, JJ; Tello, A; Villareal, D; Wong, CA, 2012) |
| "Paronychia is a well-known, but difficult to treat cutaneous toxicity associated with epidermal growth factor receptor (EGFR) inhibitor therapy." | 1.36 | Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia. ( Eames, T; Grabein, B; Kroth, J; Wollenberg, A, 2010) |
| "Telavancin was highly active against methicillin-resistant staphylococci (MIC(90), 0." | 1.35 | In vitro activity of telavancin against resistant gram-positive bacteria. ( Benton, BM; Debabov, DV; Difuntorum, S; Krause, KM; Renelli, M; Wu, TX, 2008) |
| "Ciprofloxacin resistance was observed only in hospital strains." | 1.35 | Bacillus cereus nosocomial infection from reused towels in Japan. ( Baranovich, T; Dohmae, S; Higuchi, W; Isobe, H; Itoh, M; Kobayashi, S; Okubo, T; Takano, T; Tanabe, Y; Uchiyama, M; Yamamoto, T, 2008) |
| "Ciprofloxacin-untreated rats exhibited a predominantly gram-negative polymicrobial sepsis." | 1.34 | Plasma thrombin activatable fibrinolysis inhibitor and tissue factor pathway inhibitor changes following sepsis. ( Fareed, J; Florian-Kujawski, M; Goto, M; Hammadeh, R; Hoppensteadt, D; Iqbal, O; Ravindranath, TM; Sayeed, MM, 2007) |
| " Urine samples were taken every 2 h during the whole dosing interval of the particular antibiotic." | 1.33 | Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model. ( Bedenic, B; Bubonja, M; Budimir, A; Topic, M, 2006) |
| "Cholangitis is a frequent complication of biliary stents." | 1.31 | Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis. ( Esber, E; Fogel, EL; Kalayci, C; Lehman, GA; Rerknimitr, R; Sherman, S, 2002) |
| "Trovafloxacin was 2-4 times more active than ciprofloxacin against both groups of strains." | 1.31 | Resistance to vancomycin, LY333328, ciprofloxacin and trovafloxacin of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) with and without high-level resistance to streptomycin and gentamicin. ( Blanco, MT; Gómez-García, AC; Hurtado, C; Morán, FJ; Pérez-Giraldo, C; Sánchez-Silos, RM, 2001) |
| "Ciprofloxacin was also tested against Gram-negative isolates." | 1.31 | Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections. ( Bartizal, K; Gesser, RM; Motyl, M; Pelak, BA; Woods, GL, 2002) |
| "Ciprofloxacin was the most potent study drug against the family of Enterobacteriaceae and Pseudomonas spp." | 1.30 | Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility tests. ( Barry, AL; Brown, SD; Fuchs, PC, 1999) |
| "Moxifloxacin was eight- to 32-fold more potent than ciprofloxacin and ofloxacin against staphylococci and Streptococcus pneumoniae, and equivalent to eight-fold more potent against enterococci." | 1.30 | Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin. ( Chartrand, SA; Moland, ES; Pong, A; Sanders, CC; Thomson, KS, 1999) |
| "Sparfloxacin was more active than both ciprofloxacin and ofloxacin against all the isolates tested." | 1.29 | In vitro activity of sparfloxacin, ciprofloxacin, ofloxacin, and other antibiotics against bloodstream isolates of gram-positive cocci. ( Amsterdam, D; Beam, TR; Gorzynski, EA; Mandell, LA; Rotstein, C, 1993) |
| "Trovafloxacin also showed lower MIC50 values (0." | 1.29 | Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to trovafloxacin. ( Bonilla, HF; Bradley, SF; Kauffman, CA; Zarins, LT, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 29 (26.13) | 18.2507 |
| 2000's | 47 (42.34) | 29.6817 |
| 2010's | 28 (25.23) | 24.3611 |
| 2020's | 7 (6.31) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, SG | 1 |
| Moland, ES | 2 |
| Wickman, PA | 1 |
| Black, JA | 1 |
| Hossain, A | 1 |
| Hanson, ND | 1 |
| Thomson, KS | 2 |
| Pucci, MJ | 1 |
| Cheng, J | 1 |
| Podos, SD | 1 |
| Thoma, CL | 1 |
| Thanassi, JA | 1 |
| Buechter, DD | 1 |
| Mushtaq, G | 1 |
| Vigliotti, GA | 1 |
| Bradbury, BJ | 1 |
| Deshpande, M | 1 |
| Huband, MD | 1 |
| Cohen, MA | 1 |
| Zurack, M | 1 |
| Hanna, DL | 1 |
| Skerlos, LA | 1 |
| Sulavik, MC | 1 |
| Gibson, GW | 1 |
| Gage, JW | 1 |
| Ellsworth, E | 1 |
| Stier, MA | 1 |
| Gracheck, SJ | 1 |
| Jansen, WT | 1 |
| Verel, A | 1 |
| Verhoef, J | 1 |
| Milatovic, D | 1 |
| Zhanel, GG | 1 |
| DeCorby, M | 1 |
| Laing, N | 1 |
| Weshnoweski, B | 1 |
| Vashisht, R | 1 |
| Tailor, F | 1 |
| Nichol, KA | 1 |
| Wierzbowski, A | 1 |
| Baudry, PJ | 1 |
| Karlowsky, JA | 1 |
| Lagacé-Wiens, P | 1 |
| Walkty, A | 1 |
| McCracken, M | 1 |
| Mulvey, MR | 1 |
| Johnson, J | 1 |
| Hoban, DJ | 1 |
| Krause, KM | 1 |
| Renelli, M | 1 |
| Difuntorum, S | 1 |
| Wu, TX | 1 |
| Debabov, DV | 1 |
| Benton, BM | 1 |
| Amsler, KM | 1 |
| Davies, TA | 1 |
| Shang, W | 1 |
| Jacobs, MR | 1 |
| Bush, K | 1 |
| Zheng, B | 1 |
| Tomita, H | 1 |
| Inoue, T | 1 |
| Ike, Y | 1 |
| Sader, HS | 1 |
| Fritsche, TR | 1 |
| Jones, RN | 3 |
| Makawana, JA | 1 |
| Mungra, DC | 1 |
| Patel, MP | 1 |
| Patel, RG | 1 |
| Opoku-Temeng, C | 1 |
| Naclerio, GA | 1 |
| Mohammad, H | 1 |
| Dayal, N | 1 |
| Abutaleb, NS | 1 |
| Seleem, MN | 1 |
| Sintim, HO | 1 |
| Saini, V | 1 |
| Mehta, D | 1 |
| Gupta, S | 1 |
| Kumar, S | 1 |
| Rani, P | 1 |
| Rana, K | 1 |
| Rajput, K | 1 |
| Jain, D | 1 |
| Pal, G | 1 |
| Aggarwal, B | 1 |
| Pal, S | 1 |
| Gupta, SK | 1 |
| Kumar, Y | 1 |
| Ramu, VS | 1 |
| Bajaj, A | 1 |
| Tumpa, A | 1 |
| Štritof, Z | 1 |
| Pintarić, S | 1 |
| Kang, X | 1 |
| Wei, Y | 1 |
| Fan, X | 1 |
| Luo, S | 1 |
| Luo, X | 1 |
| Zhao, S | 1 |
| Wang, G | 1 |
| Wardal, E | 1 |
| Żabicka, D | 1 |
| Hryniewicz, W | 1 |
| Sadowy, E | 1 |
| Propst, R | 1 |
| Denham, L | 1 |
| Deisch, JK | 1 |
| Kalra, T | 1 |
| Zaheer, S | 1 |
| Silva, K | 1 |
| Magaki, S | 1 |
| Shiadeh, SMJ | 1 |
| Azimi, L | 1 |
| Azimi, T | 1 |
| Pourmohammad, A | 1 |
| Goudarzi, M | 1 |
| Chaboki, BG | 1 |
| Hashemi, A | 1 |
| Dos Santos, LDR | 1 |
| Furlan, JPR | 1 |
| Gallo, IFL | 1 |
| Ramos, MS | 1 |
| Savazzi, EA | 1 |
| Stehling, EG | 1 |
| Lund, LC | 1 |
| Holzknecht, BJ | 1 |
| Justesen, US | 1 |
| Shah, MM | 1 |
| Miringu, G | 1 |
| Wada, A | 1 |
| Kaneko, S | 1 |
| Ichinose, Y | 1 |
| Ratuapli, SK | 1 |
| Lam-Himlin, DM | 1 |
| Heigh, RI | 1 |
| Blennow, O | 1 |
| Ljungman, P | 1 |
| Sparrelid, E | 1 |
| Mattsson, J | 1 |
| Remberger, M | 1 |
| Wang, QY | 1 |
| Li, RH | 1 |
| Shang, XH | 1 |
| López, Y | 1 |
| Tato, M | 1 |
| Espinal, P | 1 |
| Garcia-Alonso, F | 1 |
| Gargallo-Viola, D | 1 |
| Cantón, R | 1 |
| Vila, J | 1 |
| Sand, D | 1 |
| She, R | 1 |
| Shulman, IA | 1 |
| Chen, DS | 1 |
| Schur, M | 1 |
| Hsu, HY | 1 |
| Babics, A | 1 |
| Roussellier, P | 1 |
| Mellmann, A | 1 |
| Bletz, S | 1 |
| Böking, T | 1 |
| Kipp, F | 1 |
| Becker, K | 1 |
| Schultes, A | 1 |
| Prior, K | 1 |
| Harmsen, D | 1 |
| Bommannan, K | 1 |
| Gaspar, BL | 1 |
| Sachdeva, MU | 1 |
| Kim, MC | 1 |
| Woo, GJ | 1 |
| Lutz, P | 1 |
| Nischalke, HD | 1 |
| Krämer, B | 1 |
| Goeser, F | 1 |
| Kaczmarek, DJ | 1 |
| Schlabe, S | 1 |
| Parcina, M | 1 |
| Nattermann, J | 1 |
| Hoerauf, A | 1 |
| Strassburg, CP | 1 |
| Spengler, U | 1 |
| Al Omar, S | 1 |
| Anabtawi, N | 1 |
| Al Qasem, W | 1 |
| Rihani, R | 1 |
| Dohmae, S | 1 |
| Okubo, T | 1 |
| Higuchi, W | 1 |
| Takano, T | 1 |
| Isobe, H | 1 |
| Baranovich, T | 1 |
| Kobayashi, S | 1 |
| Uchiyama, M | 1 |
| Tanabe, Y | 1 |
| Itoh, M | 1 |
| Yamamoto, T | 1 |
| Piekarska, K | 1 |
| Gierczyński, R | 1 |
| Ławrynowicz-Paciorek, M | 1 |
| Kochman, M | 1 |
| Jagielski, M | 1 |
| Bergogne-Bérézin, E | 1 |
| Reddy, AK | 1 |
| Garg, P | 1 |
| Alam, MR | 1 |
| Gopinathan, U | 1 |
| Sharma, S | 1 |
| Krishnaiah, S | 1 |
| Ghosh, M | 1 |
| Talwani, R | 1 |
| Gilliam, BL | 1 |
| Kaya, O | 1 |
| Ozdemir, F | 1 |
| Atli, M | 1 |
| Aslan, V | 1 |
| Cağatay, M | 1 |
| Anlar, M | 1 |
| Alper, M | 1 |
| Weckwerth, PH | 1 |
| de Magalhães Lopes, CA | 1 |
| Duarte, MA | 1 |
| Weckwerth, AC | 1 |
| Martins, CH | 1 |
| Neto, DL | 1 |
| de Aguiar, HF | 1 |
| Werner, G | 1 |
| Fleige, C | 1 |
| Ewert, B | 1 |
| Laverde-Gomez, JA | 1 |
| Klare, I | 1 |
| Witte, W | 1 |
| Eames, T | 1 |
| Grabein, B | 1 |
| Kroth, J | 1 |
| Wollenberg, A | 1 |
| Cai, T | 1 |
| Mazzoli, S | 1 |
| Meacci, F | 1 |
| Boddi, V | 1 |
| Mondaini, N | 1 |
| Malossini, G | 1 |
| Bartoletti, R | 1 |
| Duncan, KO | 1 |
| Smith, TL | 1 |
| Wong, CA | 1 |
| Galvis, V | 1 |
| Tello, A | 1 |
| Villareal, D | 1 |
| Rey, JJ | 1 |
| Mhaidli, HH | 1 |
| Der-Boghossian, AH | 1 |
| Haidar, RK | 1 |
| Reuken, PA | 1 |
| Pletz, MW | 1 |
| Baier, M | 1 |
| Pfister, W | 1 |
| Stallmach, A | 1 |
| Bruns, T | 1 |
| Hewer, SL | 1 |
| Rams, TE | 1 |
| Feik, D | 1 |
| Mortensen, JE | 1 |
| Degener, JE | 1 |
| van Winkelhoff, AJ | 1 |
| Schmiemann, G | 1 |
| Gágyor, I | 1 |
| Hummers-Pradier, E | 1 |
| Bleidorn, J | 1 |
| Trifilio, SM | 1 |
| Pi, J | 1 |
| Mehta, J | 1 |
| Schelenz, S | 1 |
| Nwaka, D | 1 |
| Hunter, PR | 1 |
| Rerknimitr, R | 1 |
| Fogel, EL | 1 |
| Kalayci, C | 1 |
| Esber, E | 1 |
| Lehman, GA | 1 |
| Sherman, S | 1 |
| Jureen, R | 1 |
| Digranes, A | 1 |
| Baerheim, A | 1 |
| Torell, E | 2 |
| Kühn, I | 2 |
| Olsson-Liljequist, B | 2 |
| Haeggman, S | 1 |
| Hoffman, BM | 1 |
| Lindahl, C | 1 |
| Burman, LG | 2 |
| Rösch, T | 1 |
| Triptrap, A | 1 |
| Born, P | 1 |
| Ott, R | 1 |
| Weigert, N | 1 |
| Frimberger, E | 1 |
| Allescher, HD | 1 |
| Classen, M | 1 |
| Kamereck, K | 1 |
| Iversen, A | 1 |
| Rahman, M | 1 |
| Franklin, A | 1 |
| Möllby, R | 1 |
| Waugh, J | 1 |
| Keating, GM | 1 |
| Isenmann, R | 1 |
| Rünzi, M | 1 |
| Kron, M | 1 |
| Kahl, S | 1 |
| Kraus, D | 1 |
| Jung, N | 1 |
| Maier, L | 1 |
| Malfertheiner, P | 1 |
| Goebell, H | 1 |
| Beger, HG | 1 |
| Dow, G | 1 |
| Rao, P | 1 |
| Harding, G | 1 |
| Brunka, J | 1 |
| Kennedy, J | 1 |
| Alfa, M | 1 |
| Nicolle, LE | 1 |
| Okimoto, N | 1 |
| Yamato, K | 1 |
| Honda, Y | 1 |
| Kurihara, T | 1 |
| Osaki, K | 1 |
| Asaoka, N | 1 |
| Fujita, K | 1 |
| Ohba, H | 1 |
| Lietzau, S | 1 |
| Hoewner, M | 1 |
| von Baum, H | 1 |
| Marre, R | 1 |
| Brenner, H | 1 |
| Citak, EC | 1 |
| Oguz, A | 1 |
| Karadeniz, C | 1 |
| Okur, V | 1 |
| Basustaoglu, A | 1 |
| Arman, D | 1 |
| Leavis, HL | 1 |
| Willems, RJ | 1 |
| Top, J | 1 |
| Bonten, MJ | 1 |
| Leibovici, L | 1 |
| Paul, M | 1 |
| Cullen, M | 1 |
| Bucaneve, G | 1 |
| Gafter-Gvili, A | 1 |
| Fraser, A | 1 |
| Kern, WV | 1 |
| Bedenic, B | 1 |
| Topic, M | 1 |
| Budimir, A | 1 |
| Bubonja, M | 1 |
| Esposito, S | 2 |
| Noviello, S | 2 |
| Leone, S | 2 |
| Marvaso, A | 1 |
| Drago, L | 1 |
| Marchetti, F | 1 |
| Ianniello, F | 1 |
| O'Sullivan, CE | 1 |
| Lee, PL | 1 |
| Lemos, B | 1 |
| O'Brien, SH | 1 |
| English, JC | 1 |
| Zirwas, MJ | 1 |
| Ravindranath, TM | 1 |
| Goto, M | 1 |
| Iqbal, O | 1 |
| Florian-Kujawski, M | 1 |
| Hoppensteadt, D | 1 |
| Hammadeh, R | 1 |
| Sayeed, MM | 1 |
| Fareed, J | 1 |
| Afshari, NA | 1 |
| Ma, JJ | 1 |
| Duncan, SM | 1 |
| Pineda, R | 1 |
| Starr, CE | 1 |
| Decroos, FC | 1 |
| Johnson, CS | 1 |
| Adelman, RA | 1 |
| Burnett, RJ | 1 |
| Haverstock, DC | 1 |
| Dellinger, EP | 1 |
| Reinhart, HH | 1 |
| Bohnen, JM | 1 |
| Rotstein, OD | 1 |
| Vogel, SB | 1 |
| Solomkin, JS | 1 |
| van Tiel, FH | 1 |
| Slangen, BF | 1 |
| Schouten, HC | 1 |
| Jacobs, JA | 1 |
| Datsenko, BM | 1 |
| Tamm, TI | 1 |
| Quale, JM | 2 |
| Landman, D | 2 |
| Mobarakai, N | 2 |
| Lee, PY | 1 |
| Das, SS | 1 |
| Fombeur, JP | 1 |
| Barrault, S | 1 |
| Koubbi, G | 1 |
| Laurier, JN | 1 |
| Ebbo, D | 1 |
| Lecomte, F | 1 |
| Sorrel, N | 1 |
| Dobler, S | 1 |
| Whitman, MS | 1 |
| Pitsakis, PG | 1 |
| Zausner, A | 1 |
| Livornese, LL | 1 |
| Osborne, AJ | 1 |
| Johnson, CC | 1 |
| Levison, ME | 1 |
| McDonald, GR | 1 |
| Unal, S | 1 |
| Flokowitsch, J | 1 |
| Mullen, DL | 1 |
| Preston, DA | 1 |
| Nicas, TI | 1 |
| Rotstein, C | 2 |
| Amsterdam, D | 2 |
| Beam, TR | 1 |
| Mandell, LA | 2 |
| Gorzynski, EA | 1 |
| Zaman, MM | 1 |
| Vijayvargiya, R | 1 |
| Veis, JH | 1 |
| Bouza, P | 1 |
| García Falcón, T | 1 |
| Pérez Fontán, M | 1 |
| Rodríguez-Carmona, A | 1 |
| López Vázquez, M | 1 |
| Tresancos, C | 1 |
| Valdés, F | 2 |
| Bonilla, HF | 1 |
| Zarins, LT | 1 |
| Bradley, SF | 1 |
| Kauffman, CA | 1 |
| Hidalgo, M | 2 |
| Hornedo, J | 2 |
| Lumbreras, C | 2 |
| Trigo, JM | 1 |
| Gómez, C | 1 |
| Perea, S | 2 |
| Ruiz, A | 1 |
| Hitt, R | 1 |
| Cortés-Funes, H | 2 |
| Guirguitzova, B | 1 |
| Chankova, D | 1 |
| Zozikov, B | 1 |
| Minkov, N | 1 |
| Colsky, AS | 1 |
| Kirsner, RS | 1 |
| Kerdel, FA | 1 |
| Kaufhold, A | 1 |
| Klein, R | 1 |
| Isenberg, HD | 1 |
| Alperstein, P | 1 |
| France, K | 1 |
| Beach, ML | 1 |
| Pfaller, MA | 2 |
| Doern, GV | 1 |
| von Eiff, C | 1 |
| Peters, G | 1 |
| Hayden, MK | 1 |
| Harris, AA | 1 |
| Caldwell, JW | 1 |
| Singh, S | 1 |
| Johnson, RH | 1 |
| Barry, AL | 1 |
| Fuchs, PC | 1 |
| Brown, SD | 1 |
| Pong, A | 1 |
| Chartrand, SA | 1 |
| Sanders, CC | 1 |
| Hardy, D | 1 |
| Gomez-Martin, C | 1 |
| Solá, C | 1 |
| Valentí, V | 1 |
| Arcediano, A | 1 |
| Rodriguez, M | 1 |
| Salazar, R | 1 |
| van den Hoven, R | 1 |
| Wagenaar, JA | 1 |
| Walker, RD | 1 |
| McNeeley, DF | 1 |
| Eckert, SJ | 1 |
| Noel, GJ | 1 |
| Alexandrakis, G | 1 |
| Alfonso, EC | 1 |
| Miller, D | 1 |
| Terg, R | 1 |
| Cobas, S | 1 |
| Fassio, E | 1 |
| Landeira, G | 1 |
| Ríos, B | 1 |
| Vasen, W | 1 |
| Abecasis, R | 1 |
| Ríos, H | 1 |
| Guevara, M | 1 |
| Stilwell, M | 1 |
| Rubinstein, E | 1 |
| Diamantstein, L | 1 |
| Yoseph, G | 1 |
| Gruzman, G | 1 |
| Rubinovitch, B | 1 |
| Barzilai, A | 1 |
| Keller, N | 1 |
| Pellizzer, G | 1 |
| Strazzabosco, M | 1 |
| Presi, S | 1 |
| Furlan, F | 1 |
| Lora, L | 1 |
| Benedetti, P | 1 |
| Bonato, M | 1 |
| Erle, G | 1 |
| de Lalla, F | 1 |
| Carretto, E | 1 |
| Barbarini, D | 1 |
| Marzani, FC | 1 |
| Fumagalli, P | 1 |
| Monzillo, V | 1 |
| Marone, P | 1 |
| Emmi, V | 1 |
| Sánchez-Silos, RM | 1 |
| Pérez-Giraldo, C | 1 |
| Blanco, MT | 1 |
| Morán, FJ | 1 |
| Hurtado, C | 1 |
| Gómez-García, AC | 1 |
| Pelak, BA | 1 |
| Bartizal, K | 1 |
| Woods, GL | 1 |
| Gesser, RM | 1 |
| Motyl, M | 1 |
| Gordon, S | 1 |
| Swenson, JM | 1 |
| Hill, BC | 1 |
| Pigott, NE | 1 |
| Facklam, RR | 1 |
| Cooksey, RC | 1 |
| Thornsberry, C | 1 |
| Jarvis, WR | 1 |
| Tenover, FC | 1 |
| Hyatt, DS | 1 |
| Rogers, TR | 1 |
| McCarthy, DM | 1 |
| Samson, DS | 1 |
| Pérez-Fontán, M | 1 |
| Rosales, M | 1 |
| Fernández, F | 1 |
| Moncalián, J | 1 |
| Fernández-Rivera, C | 1 |
| Alonso, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Trial of Standard vs. Enhanced Hydration in Patients With a Diagnosis of Acute Pancreatitis Within the First Hour of the Diagnosis[NCT02709044] | Phase 2/Phase 3 | 903 participants (Anticipated) | Interventional | 2016-02-29 | Recruiting | ||
| Controlling Antimicrobial Use Through Reducing Unnecessary Treatment of Catheter Associated Urinary Tract Infections (CARCUTI)[NCT02650518] | Phase 2/Phase 3 | 500 participants (Anticipated) | Interventional | 2015-12-31 | Recruiting | ||
| Contribution of Fast Molecular Bacterial Identification by Real-time PCR in Managing of Postoperative Acute Endophthalmitis[NCT02850653] | 150 participants (Anticipated) | Interventional | 2007-11-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for ciprofloxacin and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
[Treatment of vancomycin-resistant enterococcal infections].
Topics: Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Daptomycin; Denmark; Drug Therapy, Combination; Gr | 2018 |
Sarcina ventriculi of the stomach: a case report.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Endoscopy, Digestive System; | 2013 |
[Lower urinary tract infections: bacterial epidemiology and recommendations].
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Ag | 2008 |
Inhaled antibiotics in cystic fibrosis: what's new?
Topics: Administration, Inhalation; Adolescent; Amikacin; Anti-Bacterial Agents; Aztreonam; Child; Child, Pr | 2012 |
Changing epidemiology of Clostridium difficile-associated disease during stem cell transplantation.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Aztreonam; Chicago; Ciprofloxacin; Clostridioides d | 2013 |
Ciprofloxacin extended release: in the treatment of urinary tract infections and uncomplicated pyelonephritis.
Topics: Administration, Oral; Anti-Bacterial Agents; Ciprofloxacin; Delayed-Action Preparations; Gram-Negati | 2004 |
Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
Topics: Acute Disease; Antibiotic Prophylaxis; Antineoplastic Agents; Bone Marrow Transplantation; Ciproflox | 2006 |
Cutaneous diphtheroid infection and review of other cutaneous Gram-positive Bacillus infections.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Ciprofloxacin; Corynebacterium diphtheriae; | 2007 |
Confronting antibiotic resistance in enterococcal infections.
Topics: Aminoglycosides; beta-Lactam Resistance; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, | 1994 |
13 trials available for ciprofloxacin and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bac | 2008 |
Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial.
Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Female; Gram-Negative Bacter | 2004 |
A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury.
Topics: Acute Disease; Adult; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Enterobacter | 2004 |
Clinical effect of intravenous ciprofloxacin on hospital-acquired pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Bac | 2005 |
A pilot study on prevention of catheter-related urinary tract infections with fluoroquinolones.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; | 2006 |
Definition of the role of enterococcus in intraabdominal infection: analysis of a prospective randomized trial.
Topics: Abscess; Adult; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Double-Blind Method; Drug Resistan | 1995 |
Study of the efficacy and safety of ciprofloxacin in the treatment of chronic sinusitis.
Topics: Adult; Chronic Disease; Ciprofloxacin; Female; Gram-Negative Bacterial Infections; Gram-Positive Bac | 1994 |
Lack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplants.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antineoplastic Com | 1997 |
Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Cost-Benefit Analysis; Cross Infection; Double-Blind Me | 1999 |
Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antineoplastic Age | 2000 |
Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study.
Topics: Administration, Oral; Analysis of Variance; Anti-Infective Agents; Ascitic Fluid; Ciprofloxacin; Cre | 2000 |
Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection.
Topics: Adult; Bacterial Infections; Biopsy; Ciprofloxacin; Clindamycin; Corynebacterium; Diabetic Foot; Dru | 2001 |
A randomized trial of ciprofloxacin plus azlocillin versus netilmicin plus azlocillin for the empirical treatment of fever in neutropenic patients.
Topics: Azlocillin; Ciprofloxacin; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gra | 1991 |
89 other studies available for ciprofloxacin and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
In vitro studies with DQ-113 and comparison fluoroquinolones to determine propensities to select resistance in gram-positive cocci.
Topics: Drug Resistance, Bacterial; Drug Resistance, Microbial; Fluoroquinolones; Gram-Positive Bacterial In | 2007 |
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Ba | 2007 |
In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groups.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple; Gram-Positive Bacteria | 2007 |
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Europe; Gram-Positive | 2007 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; | 2008 |
In vitro activity of telavancin against resistant gram-positive bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bact | 2008 |
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Bacteriocins; Blotting, Southern; Co | 2009 |
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Europe; Gram-Positive Bacterial Infections; Gram-Posit | 2009 |
Microwave assisted synthesis and antimicrobial evaluation of new fused pyran derivatives bearing 2-morpholinoquinoline nucleus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Candida albicans; Fungi; Gram-Negative Bacte | 2011 |
N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria.
Topics: Animals; Anti-Bacterial Agents; Benzamides; Disease Models, Animal; Dose-Response Relationship, Drug | 2018 |
Targeting Vancomycin-Resistant
Topics: Anti-Bacterial Agents; Cholic Acid; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; | 2022 |
Prevalence and antimicrobial susceptibility of Enterococcus spp. from urine of dogs and cats in northwestern Croatia.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cat Diseases; Cats; Chloramphenic | 2022 |
Analysis of virulence genes, drug resistance detection, and pathogenicity in Enterococcus from farm animals.
Topics: Animals; Animals, Domestic; Anti-Bacterial Agents; Cattle; Cefotaxime; Chickens; Ciprofloxacin; Dogs | 2022 |
VanA-Enterococcus faecalis in Poland: hospital population clonal structure and vanA mobilome.
Topics: Aminoglycosides; Bacterial Proteins; Carbon-Oxygen Ligases; Ciprofloxacin; DNA Transposable Elements | 2022 |
Topics: Aged; Anti-Bacterial Agents; Child; Ciprofloxacin; Esophagus; Female; Gram-Positive Bacterial Infect | 2020 |
Upregulation of efrAB efflux pump among Enterococcus faecalis ST480, ST847 in Iran.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Biofilms; Ciprofloxacin; DNA, Bacterial; D | 2020 |
Occurrence of multidrug-resistant Enterococcus faecium isolated from environmental samples.
Topics: Aminoglycosides; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; DNA, Bacterial; Drug Resista | 2021 |
Case Report:
Topics: Anti-Bacterial Agents; Bacillus pumilus; Ciprofloxacin; Feces; Foodborne Diseases; Gram-Positive Bac | 2019 |
Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anti-Infective Agents; Bacteremia; Candidiasis; Child; Chil | 2014 |
Urinary tract infection caused by Enterococcus isolates: aetiology and antimicrobial resistance patterns.
Topics: Academic Medical Centers; Ampicillin Resistance; Anti-Infective Agents, Urinary; China; Ciprofloxaci | 2015 |
In vitro selection of mutants resistant to ozenoxacin compared with levofloxacin and ciprofloxacin in Gram-positive cocci.
Topics: Aminopyridines; Anti-Bacterial Agents; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Gr | 2015 |
Microbial keratitis in los angeles: the doheny eye institute and the los angeles county hospital experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Child; Ciprofloxacin; C | 2015 |
Gardnerella vaginalis: An overlooked pathogen in male patients?
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bacteremia; Ceftriaxone; Ciprofloxacin; Drug Resistance, | 2015 |
Real-Time Genome Sequencing of Resistant Bacteria Provides Precision Infection Control in an Institutional Setting.
Topics: Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Cross Infection; Enterococcus faecium; Escherichia | 2016 |
Pathogenic Sarcina in urine.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Gram-Positive Bacterial Infections; | 2016 |
Characterization of antimicrobial resistance and quinolone resistance factors in high-level ciprofloxacin-resistant Enterococcus faecalis and Enterococcus faecium isolates obtained from fresh produce and fecal samples of patients.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Crops, Agricultural; Drug Resistance, Bacterial; Enterococcus | 2017 |
Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Ceftriaxone; Ciprofloxacin; Cross Infection; Drug | 2017 |
Bacterial Infections in Children With Acute Myeloid Leukemia Receiving Ciprofloxacin Prophylaxis.
Topics: Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Child; | 2017 |
Bacillus cereus nosocomial infection from reused towels in Japan.
Topics: Adult; Aged, 80 and over; Anti-Bacterial Agents; Bacillus cereus; Bacteremia; Bacterial Toxins; Bedd | 2008 |
Novel gyrase mutations and characterization of ciprofloxacin-resistant clinical strains of Enterococcus faecalis isolated in Poland.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; DNA Gyrase; DNA Topois | 2008 |
Comparison of in vitro susceptibilities of Gram-positive cocci isolated from ocular infections against the second and fourth generation quinolones at a tertiary eye care centre in South India.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Eye Infections, Bacterial; Female; Fluoroquinol | 2010 |
Propionibacterium skull osteomyelitis treated with daptomycin.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Gram-Positive Bacterial Infections; Humans; Male; | 2009 |
The effects of ciprofloxacin and ursodeoxycholic acid on bacterial translocation in obstructive jaundice.
Topics: Animals; Anti-Infective Agents; Bacterial Translocation; Cholagogues and Choleretics; Ciprofloxacin; | 2009 |
Chronic suppurative otitis media in cleft palate: microorganism etiology and susceptibilities.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteria; Child; Child, Preschool; Chronic Disease; Ciprof | 2009 |
High-level ciprofloxacin resistance among hospital-adapted Enterococcus faecium (CC17).
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Ciprofloxacin; Cluster Analysis; DNA Fingerprint | 2010 |
Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Age | 2010 |
Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Enterococcus fa | 2011 |
Primary cutaneous infection with Bacillus megaterium mimicking cutaneous anthrax.
Topics: Adult; Anthrax; Bacillus megaterium; Ciprofloxacin; Diagnosis, Differential; Female; Follow-Up Studi | 2011 |
[In vitro antibiotic susceptibility to fluoroquinolones].
Topics: Acanthamoeba Keratitis; Anti-Bacterial Agents; Aza Compounds; Body Fluids; Ciprofloxacin; Colombia; | 2012 |
Propionibacterium acnes delayed infection following spinal surgery with instrumentation.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Delayed Diagnosis; Disease Progression; Fistula; Follow- | 2013 |
Emergence of spontaneous bacterial peritonitis due to enterococci - risk factors and outcome in a 12-year retrospective study.
Topics: Aged; Analysis of Variance; Anti-Infective Agents; Ascitic Fluid; Cephalosporins; Ciprofloxacin; Ent | 2012 |
Antibiotic susceptibility of periodontal Enterococcus faecalis.
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti- | 2013 |
Resistance profiles of urinary tract infections in general practice--an observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, B | 2012 |
Longitudinal surveillance of bacteraemia in haematology and oncology patients at a UK cancer centre and the impact of ciprofloxacin use on antimicrobial resistance.
Topics: Anti-Bacterial Agents; Bacteremia; Cancer Care Facilities; Ciprofloxacin; Drug Resistance, Bacterial | 2013 |
Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bile; Chil | 2002 |
[Urinary tract pathogens in uncomplicated lower urinary tract infections in women in Norway].
Topics: Adult; Aged; Amdinocillin; Ampicillin; Ampicillin Resistance; Anti-Infective Agents, Urinary; Bacter | 2003 |
Clonality among ampicillin-resistant Enterococcus faecium isolates in Sweden and relationship with ciprofloxacin resistance.
Topics: Ampicillin; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Multip | 2003 |
Bacteriobilia in percutaneous transhepatic biliary drainage: occurrence over time and clinical sequelae. A prospective observational study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bile Ducts, Intrahepatic; Biliary Tract Surgi | 2003 |
Evidence for transmission between humans and the environment of a nosocomial strain of Enterococcus faecium.
Topics: Ampicillin Resistance; Animals; Anti-Infective Agents; Bacterial Typing Techniques; Carrier State; C | 2004 |
Antibiotic resistant fecal isolates of Enterococci among unselected patients outside the clinical sector: an epidemiological study from Southern Germany.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Doxycycline; Drug Resistance, Multipl | 2006 |
First recurrent infection with vancomycin-resistant enterococcus from Turkey.
Topics: Anti-Bacterial Agents; Bacteremia; Child, Preschool; Ciprofloxacin; Enterococcus faecium; Female; Gr | 2006 |
High-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium.
Topics: Base Sequence; Ciprofloxacin; Cross Infection; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Dru | 2006 |
Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model.
Topics: Acetamides; Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; | 2006 |
[In vitro activity of prulifloxacin, levofloxacin and ciprofloxacin against urinary pathogens].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dioxolanes; Drug Resistance, Multiple, Bacterial; Fluoroquinol | 2006 |
Intraaortic vegetations and infective endocarditis.
Topics: Anti-Infective Agents; Aorta, Thoracic; Ciprofloxacin; Drug Combinations; Echocardiography, Transeso | 2007 |
Plasma thrombin activatable fibrinolysis inhibitor and tissue factor pathway inhibitor changes following sepsis.
Topics: Animals; Carboxypeptidase B2; Ciprofloxacin; Enterococcus faecalis; Gram-Negative Bacterial Infectio | 2007 |
Trends in resistance to ciprofloxacin, cefazolin, and gentamicin in the treatment of bacterial keratitis.
Topics: Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Drug Resistance, Bacterial; Eye Infections, Bacteri | 2008 |
Study of Stomatococcus mucilaginosus isolated in a hospital ward using phenotypic characterization.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Cluster Analysis; Colony Count, Microbial; Cross Infection; Dr | 1995 |
[The efficacy of the clinical use of the preparation Cifran in treating surgical infection].
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Drug Evaluation; Female; Fluor | 1994 |
Treatment of experimental endocarditis due to multidrug resistant Enterococcus faecium with ciprofloxacin and novobiocin.
Topics: Animals; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gr | 1994 |
Endocarditis due to high-level gentamicin-resistant Enterococcus faecalis.
Topics: Adult; Ampicillin; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditi | 1995 |
Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium.
Topics: Ampicillin Resistance; Animals; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Microbial; D | 1993 |
Endocarditis after ciprofloxacin therapy for enterococcal pyelonephritis with bacteremia.
Topics: Aged; Bacteremia; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus fa | 1993 |
In-vitro synergy and mechanism of interaction between vancomycin and ciprofloxacin against enterococcal isolates.
Topics: Bacterial Outer Membrane Proteins; Cell Membrane; Ciprofloxacin; Drug Resistance, Microbial; Drug Sy | 1993 |
In vitro activity of sparfloxacin, ciprofloxacin, ofloxacin, and other antibiotics against bloodstream isolates of gram-positive cocci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquino | 1993 |
Intravenous ciprofloxacin: a position statement by the Society of Infectious Diseases Pharmacists.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Humans; Injections, I | 1993 |
Ampicillin plus ciprofloxacin therapy of experimental endocarditis caused by multidrug-resistant Enterococcus faecium.
Topics: Ampicillin; Animals; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, | 1995 |
Antibiotic-resistant endocarditis in a hemodialysis patient.
Topics: Ampicillin; Bacteremia; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug T | 1996 |
Treatment of CAPD-related peritonitis with ciprofloxacin: results after seven years.
Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Gram-Negative Bacterial Infections; Gram | 1996 |
Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to trovafloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus faecium; Fluoroquinol | 1996 |
[Enterococci as uropathogens. Frequency of isolation and sensitivity to antibacterial agents].
Topics: Adult; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriuria; beta-Lactama | 1998 |
Analysis of antibiotic susceptibilities of skin wound flora in hospitalized dermatology patients. The crisis of antibiotic resistance has come to the surface.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Dermatitis; Drug Resistance, Microbial; | 1998 |
Species identification and antibiotic susceptibility of enterococci isolated from clinical specimens of hospitalized patients.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Enterococcus; Erythromycin; Gram-Positive Bacteria | 1995 |
In vitro susceptibility of recent gram-positive isolates to ciprofloxacin, levofloxacin, and trovafloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Corynebacterium; Drug Resistance, Microbial; Fluoroquinolones; | 1998 |
Antimicrobial activity of gatifloxacin tested against 1676 strains of ciprofloxacin-resistant gram-positive cocci isolated from patient infections in North and South America.
Topics: Anti-Infective Agents; Antitubercular Agents; Bacteriological Techniques; Ciprofloxacin; Drug Resist | 1998 |
In vitro activity of ciprofloxacin, ofloxacin, and levofloxacin against Micrococcus species and Stomatococcus mucilaginosus isolated from healthy subjects and neutropenic patients.
Topics: Anti-Infective Agents; Ciprofloxacin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Human | 1998 |
Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility tests.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Aerobic; Ciprofloxacin; Fluoroquinolones; Gram-Negat | 1999 |
Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; G | 1999 |
Comparative in vitro activities of ciprofloxacin, gemifloxacin, grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of gram-positive cocci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Fluoroquinol | 2000 |
In vitro activity of difloxacin against canine bacterial isolates.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Dog Diseases; Dogs; Dose-Response Relationship, Drug; | 2000 |
Antimicrobial-resistant enterococcal isolates from fluoroquinolone-naive children.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child, Preschool; Ciprofloxacin; Drug Resi | 2000 |
Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Cornea; Corneal Ulcer; Drug R | 2000 |
Activity and spectrum of BMS 284756, a new des-F (6) quinolone, tested against strains of ciprofloxacin-resistant Gram-positive cocci.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gram-Positive Ba | 2001 |
The effect of albumin, globulin, pus and dead bacteria in aerobic and anaerobic conditions on the antibacterial activity of moxifloxacin, trovafloxacin and ciprofloxacin against Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli.
Topics: Albumins; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Escherichia coli; Escherichia coli In | 2000 |
Catheter-related bacteremia due to Lactobacillus rhamnosus in a single-lung transplant recipient.
Topics: Adult; Anti-Infective Agents; Bacteremia; Catheterization; Ciprofloxacin; Equipment Contamination; G | 2001 |
Resistance to vancomycin, LY333328, ciprofloxacin and trovafloxacin of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) with and without high-level resistance to streptomycin and gentamicin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Cross In | 2001 |
Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections.
Topics: Aerobiosis; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial | 2002 |
Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; beta-Lactamases; Child; Child, Preschoo | 1992 |
Ciprofloxacin in the treatment of gram-positive bacterial peritonitis in patients undergoing CAPD.
Topics: Administration, Oral; Ciprofloxacin; Gram-Positive Bacterial Infections; Humans; Injections, Intrape | 1991 |